Eszopiclone 3 mg

DRUG6 trials

Sponsors

Eisai Co., Ltd., Sumitomo Pharma America, Inc., University of Sao Paulo General Hospital, Flinders University, University of Sao Paulo

Conditions

HypertensionInsomniaOSA - Obstructive Sleep ApneaObstructive Sleep ApneaPrimary Insomnia

Phase 1

A Bioequivalence and Food Effect Study of SEP-190 in Japanese Healthy Subjects (Study SEP 190-102)

CompletedNCT01055834

Eisai Co., Ltd.Insomnia

Start: 2010-01-31End: 2010-02-28Updated: 2013-02-12

Phase 2

A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)

CompletedNCT00770510

Eisai Co., Ltd.Primary Insomnia

Start: 2008-09-30End: 2010-05-31Updated: 2013-02-04

Effects of Eszopiclone and Lemborexant in People With OSA With a Low Arousal Threshold Who Have Difficulty Sleeping

RecruitingNCT06928766

Flinders UniversityOSA - Obstructive Sleep Apnea

Start: 2025-10-31End: 2027-06-30Target: 15Updated: 2026-09-02

Phase 3

Twelve Month Study of the Safety of Eszopiclone in Adult Subjects With Insomnia

CompletedNCT01710631

Sumitomo Pharma America, Inc.Primary Insomnia

Start: 2001-02-28End: 2002-08-31Updated: 2012-10-22

Phase 4

Effect of Eszopiclone on Adherence to CPAP and Severity of Insomnia in Patients With COMISA

CompletedNCT06017921

University of Sao Paulo General HospitalInsomnia, Obstructive Sleep Apnea

Start: 2023-08-24End: 2026-03-20Updated: 2026-05-29

Impact of Eszopiclone on Blood Pressure in Patients With Insomnia and Hypertension (PRYSMA-HTN)

RecruitingNCT07018557

University of Sao PauloHypertension, Insomnia

Start: 2025-06-04End: 2026-12-31Target: 150Updated: 2025-06-12